Navigation Links
Generex Provides Clarification of Facts
Date:6/27/2011

WORCESTER, Mass. and TORONTO, June 27, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT) (www.generex.com) today provided a clarification of facts arising out of a blog post on Friday, June 24, 2011.  Following that blog post, the price of the Company's common stock fell more than 20% and more than 4 million shares were traded.

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b)

The author of the blog post made reference to information Generex provided to the marketplace in a press release eight days earlier (on June 16, 2011).  Generex management feels it necessary and appropriate to clarify certain assertions made by the author in the blog post that, in the opinion of Generex, mischaracterize certain facts regarding Generex and the progress of Generex Oral-lyn™, the Company's proprietary oral insulin spray product.

Generex "closed" the recent Phase III clinical trial of Generex Oral-lyn™ because the trial had been completed in accordance with the clinical trial protocol.  The blog author's assertion that Generex "shut down" the trial inappropriately implies that the trial was curtailed or flawed, which is not the case. Further, the trial was completed on schedule in accordance with the clinical trial protocol.

The June 16 Generex press release stated:  "Generex clinical trial 084 in patients with type 1 diabetes will be closed to allow a final data analysis to guide future clinical trial plans.  Interim results demonstrated that the type 1 patients treated with Generex Oral-lyn™ maintained metabolic control (hemoglobin A1c) over the 12 month duration of the trial." In short, these results validated our proprietary buccal insulin delivery technology.

Generex disclosed the positive interim findings of the Phase III trial at the annual meeting of stockholders on June 8, 2011 and outlined how it has begun to execut
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Generex Announces Results of Annual Stockholders Meeting
2. Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes
3. Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia
4. Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research
5. Generex Announces $3.0 Million Capital Investment
6. Generex Provides Additional Details for October 21st Live Video Webcast
7. Generex Common Stock to be Quoted on the OTCQB Under the Symbol GNBT Beginning Thursday, October 21, 2010
8. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
9. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
10. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
11. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014  Neogen Corporation (Nasdaq: ... first quarter of its 2015 fiscal year, which ended ... to net income of $7,839,000 in the first quarter ... effective Oct. 30, 2013, earnings per share in the ... ago. First quarter revenues increased 15% to ...
(Date:9/22/2014)... -- The US markets on Friday, September ... Dow Jones Industrial Average finished at 17,279.74, up 0.08% ... The S&P 500 finished the session 0.05% lower at ... sectors finished on a positive note. The S&P 500 ... up 0.10%, with the index gaining 6.95% in the ...
(Date:9/22/2014)... , Sept. 22, 2014  Spherix Incorporated (SPEX) -- ... monetization of intellectual property, today announced that the United States ... the Company in the month of September that is part ... The issued patent is: USRE45,121 , Application number: ... , Filing date: Dec 27, 2012 The ...
(Date:9/21/2014)... September 21, 2014 Chemical Sciences ... challenges such as clean air and safe water, ... natural products. Chemists, environmentalists, food scientists, educators, and ... research in the field of Chemistry for the ... Sciences is one of the fastest emerging Sciences, ...
Breaking Biology Technology:Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 5Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3Chemistry for Global Development during the Open Access Week 2Chemistry for Global Development during the Open Access Week 3
... New Report Added in ResearchMoz Reports ... Spending Estimates and Forecasts) The ... past ten years suggests the amount of vaccine production ... adapt to match a revived industry. This ...
... 15, 2012 Healthcare organizations are becoming more efficient ... creating a more connected patient care environment. But to ... information, especially the electronic medical record (EMR) and enterprise ... Software, a leader in ECM for healthcare , ...
... improve infrared photodetector technology that is critical to national ... in commercial applications and consumer products. A significant ... journal Applied Physics Letters . It ... more effectively by using certain materials arranged in specific ...
Cached Biology Technology:ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and Forecasts) 2ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and Forecasts) 3ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and Forecasts) 4ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and Forecasts) 5Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System 2Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System 3New nano-material combinations produce leap in infrared technology 2New nano-material combinations produce leap in infrared technology 3
(Date:9/19/2014)... not evolve for the sake of fairness per se ... cooperation, so say Frans de Waal, PhD, and Sarah ... aversion (IA), which is defined as a negative reaction ... Science . , Their conclusion comes after the ... their hypothesis that it is the evolution of forestalling ...
(Date:9/19/2014)... study shows that legume plants regulate their symbiotic ... that are transmitted through the plant structure from ... of bacteria-holding nodules in the roots. This collaborative ... Institute for Basic Biology, the Graduate University for ... Sustainable Resource Science in Japan. , Legumes, ...
(Date:9/18/2014)... A sleep-promoting circuit located deep in the primitive brainstem ... by researchers at Harvard School of Medicine and the ... this is only the second "sleep node" identified in ... necessary and sufficient to produce deep sleep. , Published ... study demonstrates that fully half of all of the ...
Breaking Biology News(10 mins):Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3For legume plants, a new route from shoot to root 2No sedative necessary: Scientists discover new 'sleep node' in the brain 2
... sunlight decreases the toxicity of golden algae, which kills millions ... While golden algae is primarily a coastal species, it has ... and Lake Waco in Central Texas, and Lake Granbury in ... production, but new research from Baylor scientists shows that sunlight ...
... International and American Associations for Dental Research (IADR/AADR) have ... and Pulp Regeneration," held in Geneva, Switzerland, July 2010. ... and Regeneration Group, and they are published in volume ... an E-supplement to the Journal of Dental Research ...
... CAMBRIDGE, Mass. -- The first organisms to emerge ... skills, arming themselves with tough exteriors to weather a ... Smith College have discovered hundreds of microscopic fossils in ... time when the planet emerged from a global glaciation, ...
Cached Biology News:IADR/AADR publish proceedings from Symposium on Tissue Injury and Pulp Regeneration 2MIT research: Life after 'Snowball Earth' 2MIT research: Life after 'Snowball Earth' 3
Panomer 9 oligodeoxynucleotides are random primers that are labeled at the 5' end with our proprietary QSY 7 dye and they are useful for assessing microarray spot morphology, hybridization potential ...
... l-[U-14C]methionine, 1.85 MBq, 50 uCi. Aqueous ... > 1.85 GBq/mg atom carbon, > ... of Ala, Arg, Asp, Glu, Gly, ... Ser, Thr, Tyr and Val.1.85 MBq/ml, ...
Topoisomerase I, isolated from wheat germ, is an enzyme capable of removing negative supercoils from covalently closed circular DNA (1)....
Request Info...
Biology Products: